Lower HMGCS2 expression is linked to gut inflammation in IBD.[105] However, this effect could be reversed by BHB via a HMGCS2‐dependent pathway, reducing proinflammatory chemokine responses in intestinal cells.[105] This evidence indicates the immunometabolic role of ketogenesis in regulating gut immunity. The gene discussed is HMGCS2; the disease is irritable bowel syndrome.